13F Portfolios

Lynx1 Capital Management LP: NEUPHORIA THERAPEUTICS INC (NEUP): Quarterly 13F Position History

As of Q2 2026, Lynx1 Capital Management LP reported 875,328 shares of NEUPHORIA THERAPEUTICS INC (NEUP), worth $3.8M and representing 0.8% of its 13F equity book. The position first appeared in Q4 2024 and has been disclosed across 7 13F-HR filings in Pactolio's tracked window.

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 7 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q2 2026 875,328 0 $3.8M 0.8% $4.4
Q1 2026 875,328 +100 +0.0% $3.6M 0.6% $4.1
Q4 2025 875,228 +875,228 $3.4M 0.7% $3.9
Q3 2025 0 45,806 -100.0% $0 0.0%
Q2 2025 45,806 0 $325.2K 0.1% $7.1
Q1 2025 45,806 0 $263.8K 0.1% $5.8
Q4 2024 45,806 $157.1K 0.1% $3.4

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.

When did Lynx1 Capital Management LP first disclose a NEUP position in 13F-HR filings?

Lynx1 Capital Management LP first reported NEUPHORIA THERAPEUTICS INC (NEUP) on its 13F-HR filing for the period ending 2024-12-31 (Q4 2024). The position has appeared on 7 reported quarters within Pactolio's tracked window.

What was Lynx1 Capital Management LP's most recent quarter-over-quarter share-count change in NEUP?

Lynx1 Capital Management LP held the same 875,328 shares of NEUP between Q1 2026 and Q2 2026, so the reported share count was unchanged quarter-over-quarter.

Does the implied price-per-share represent Lynx1 Capital Management LP's cost basis in NEUP?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.